lanraplenib
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for lanraplenib, covering 2019-10-25 to 2020-05-18. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN) [Phase 2]